We are excited to announce our participation at CPHI Worldwide 2024, which will be held from October 8th-10th in Milan. You can find us at booth #5D74. This premier event provides a unique opportunity to showcase our global CDMO capabilities and grant attendees access to engage with pharmaceutical professionals from around the world.
CPHI Milano 2024
Dates: October 8th (Tue) – 10th (Thu), 2024
Venue: Fiera Milano, Italy
Booth: #5D74
Understanding CPHI
CPHI, or Convention on Pharmaceutical Ingredients, is a landmark event in the pharmaceutical industry. It is a crucial meeting point where pharmaceutical research, development, and manufacturing come together to foster partnerships aimed at advancing therapies and innovations for patients worldwide. It covers the entire supply chain, from raw ingredients to finished products, facilitating crucial connections and discussions about the latest trends and challenges. As a comprehensive platform, CPhI Worldwide serves as a vital hub for innovation and industry insights.
CPHI Milan 2024
This year’s CPHI Worldwide will be hosted in Milan, Italy, from October 8-10. Known for its vibrant business environment and rich cultural heritage, Milan offers an ideal backdrop for this major pharmaceutical event. Attending in person provides invaluable face-to-face interactions, allowing industry professionals to connect, network, and engage in discussions that drive innovation and collaboration. The city’s central location and modern facilities make it an excellent venue for exploring new developments.
Ownership and Organization
CPHI is organized by Informa Markets, a global leader in events and information services. Informa Markets is renowned for its extensive portfolio of industry-leading events, including CPHI Worldwide. Their expertise ensures that CPHI remains a premier platform for pharmaceutical industry professionals to network and advance their business goals.
Adragos Pharma: A Global CDMO Leader
Adragos Pharma is a leading Contract Development and Manufacturing Organization (CDMO) headquartered in Munich, Germany. We are dedicated to fulfilling the pharmaceutical needs of clients across Europe, Japan, and North America. Our approach is grounded in a customer-centric philosophy that guarantees exceptional quality and service in every aspect of our operations.
Our Offering
We offer a comprehensive range of Contract Development and Manufacturing Organization (CDMO) services tailored to meet the diverse needs of the pharmaceutical industry. Our end-to-end solutions include drug product development, encompassing out-licensing, custom analysis, and advanced formulation services. We provide reliable manufacturing for small molecule finished dosage forms (FDFs), including sterile and non-sterile liquids, solids, and semi-solids. With state-of-the-art facilities across Europe and Japan, we ensure exceptional quality and efficiency throughout the entire process, from initial planning and supply chain management to regulatory affairs, making us a trusted partner for pharmaceutical companies worldwide.
Our Facilities
We operate a network of cutting-edge facilities across Europe and Japan, including state-of-the-art sites in Athens, Halden, Kawagoe, Livron, and Leipzig. Each facility is equipped with advanced technology and staffed by dedicated experts, ensuring top-notch quality in the development and manufacturing of pharmaceutical products. From sterile and non-sterile liquid formulations to advanced R&D capabilities, our facilities support a wide range of dosage forms and services, meeting the highest standards in the industry.
Meet Our Experts
At CPHI Milan 2024, various members of our team from different facilities will come together for this event. Here is a brief introduction to 3 key members:
Andreas Raabe, Chief Executive Officer (CEO): Andreas leads Adragos Pharma’s strategic direction and innovation efforts, bringing extensive experience and vision to the company’s initiatives.
Marco Gorgas, Chief Technical Officer (CTO): Marco oversees the technical aspects of operations, ensuring the integration of cutting-edge technologies and best practices in pharmaceutical manufacturing.
Henny Zijlstra, Chief Commercial Officer (CCO): Henny manages the commercial strategy and client relationships, driving growth and expanding Adragos Pharma’s market presence.
Visitors to booth #5D74 will have the opportunity to engage with these industry leaders, gain insights into our latest innovations, and discuss how our solutions can address current industry challenges.
Key Highlights to Expect
Technology: At CPHI Milan 2024, we will showcase their technological advancements and sustainable practice in pharmaceutical manufacturing.
Networking Opportunities: The event will offer numerous opportunities for pharma professionals to connect, discuss potential collaborations, and build valuable relationships. Thousands of professionals from around the globe will gather to engage in business transactions, knowledge exchange, and fostering partnerships that drive innovation within the pharmaceutical sector.
Educational Sessions: Attendees can participate in sessions covering the latest trends, emerging challenges, and future directions in the pharmaceutical industry. These sessions will be led by experts and provide valuable insights.
Exhibitions: From advanced manufacturing equipment to new packaging solutions, the exhibitions at CPHI Milan will offer a comprehensive view of the tools and technologies shaping the industry.
Focus on Sustainability: Emphasizing the importance of sustainable practices, the event will highlight innovations aimed at reducing environmental impact and promoting greener manufacturing processes.
CPHI Worldwide 2024 in Milan promises to be a pivotal event for the pharmaceutical industry. With its focus on innovation, networking, and the latest trends, it provides a valuable platform for professionals to connect and explore new opportunities. Our participation at booth #5D74 underscores our commitment to advancing pharmaceutical manufacturing and addressing the industry’s evolving needs.
FAQs about CPHI
What does CPHI mean?
CPHI stands for Convention on Pharmaceutical Ingredients, a global event that covers the entire pharmaceutical supply chain. CPHI Pharma refers to the segment of CPHI Worldwide dedicated to pharmaceutical ingredients, contract manufacturing, and R&D, offering a platform for industry professionals to showcase and explore new innovations.
Where will CPHI 2024 be held?
CPHI Worldwide 2024 will be held in Milan, Italy.
Who owns CPHI?
CPHI is organized by Informa Markets, a global events and information services provider.
Where is CPHI Europe 2025?
CPHI Europe 2025 will take place in Messe Frankfurt, scheduled for 28-30 October. The event will bring together the entire supply chain, from ingredients and finished dosages to machinery, bio, packaging, and more.
